ALBIGLUTIDE

This drug belongs to a class of drugs called GLP-1 receptor agonists. A class of drugs refers to medications that work similarly. This drug increases the amount of insulin released in your body and slows the emptying of your stomach. This helps control your blood sugar levels.

When used with diet and exercise, this drug is used to improve blood sugar control in adults with type 2 diabetes.

Albiglutide can cause severe low blood sugar. Your risk of severe low blood sugar may be higher if you’re taking Albiglutide with other diabetes medications that can cause low blood sugar. Make sure you know the signs and symptoms of low blood sugar.

The most common side effects that occur with albiglutide are:

  • diarrhea
  • nausea
  • reactions at your injection site
  • cough
  • back pain
  • cold or flu symptoms

Mild side effects may go away within a few days or a couple of weeks. Talk to your doctor or pharmacist if they’re more severe or don’t go away.

Precautions

Before you start albiglutide, you should be trained by your doctor on the correct way to inject it. Talk to your doctor or pharmacist if you have questions or if you don’t understand the instructions.

 

Interactions

Your doctor should manage all of your medications carefully because this drug can interact with other medications, herbs, or vitamins you might be taking. To know more about these interactions, talk to your doctor or pharmacist.

Symptoms that appear when you take too much of this drug includes severe nausea, vomiting, and headache.

 

Available brand:

  • Tanzeum

Related Articles

Vaccine, DTP

DTP vaccine (Diphtheria and Tetanus toxoids and Pertussis adsorbed vaccine) is a combination vaccine used to induce specific antibody production, thus promoting immunity [...]

Teicoplanin

Teicoplanin is a glycopeptide antibiotic drug that inhibits the growth of susceptible organisms by disrupting cell-wall synthesis. It binds to D-alanyl-D-alanine residues resulting to peptidoglycan synthesis blockage. Use this [...]

Secukinumab

Secukinumab is a human monoclonal antibody, Immunoglobulin G1/K that binds selectively to interleukin-17A (IL-17A), a natural cytokine affecting normal inflammatory and immune responses. It inhibits the release [...]